Contraception News and Research

Latest Contraception News and Research

Abortions worldwide decline, unsafe abortions kill 70,000 women annually, report says

Fewer abortions are taking place worldwide because of increased contraceptive use, a study by the Guttmacher Institute has found, Reuters reports. The study also indicates that 20 million "unsafe abortions, mostly in poorer countries and often carried out by the women themselves using inappropriate drugs or herbal potions, or by untrained traditional healers," still occur each year and kill 70,000 women annually (Kelland, 10/13).

15 Oct 2009

Also in Global Health News: Ban addresses women's health; Afghanistan's health services; PMI Africa grants; Q&As

U.N. Secretary-General Ban Ki-Moon on Monday called for countries around the world to "renew their commitment to educate girls, end sexual violence, and provide access to modern birth control," the Associated Press/Washington Post reports.

14 Oct 2009

USAID awards Abt Associates 'Strengthening Health Outcomes Through Private Sector' grant

The United States Agency for International Development (USAID) has awarded a five-year grant, Strengthening Health Outcomes through the Private Sector, to Abt Associates, Inc. Sub-recipients under the grant are Banyan Global, Jhpiego, Marie Stopes International, the Monitor Group, and O'Hanlon Health Consulting, LLC.

13 Oct 2009

Study reveals that teenage boys are less responsible than girls in preventing chlamydia

Teenage boys in Sweden take less responsibility than girls for preventing the spread of chlamydia and other sexually transmitted infections, according to a new study from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

13 Oct 2009

Birth control pills may have an impact on choice of partners

There is no doubt that modern contraception has enabled women to have unprecedented control over their own fertility. However, is it possible that the use of oral contraceptives is interfering with a woman's ability to choose, compete for and retain her preferred mate?

8 Oct 2009

Multiple intervention programs can reduce teen pregnancies

When teenagers receive health education and information about contraception, the number of them having unintended pregnancies decreases, finds a large new review.

7 Oct 2009

Schering-Plough receives FDA recommendation approval for PEGINTRON

Schering-Plough Corp. announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for PEGINTRON® (pegylated interferon alfa-2b) in the adjuvant treatment of patients with Stage III malignant melanoma.

6 Oct 2009

Jon O'Brien's statement on healthcare reform

"This Sunday, the United States Conference of Catholic Bishops holds its annual Respect Life Sunday. On this occasion, we would like to encourage the US bishops to also respect the truth. A recent publication by the USCCB, a brochure entitled Contraception: The Fine Print, and recent polls on healthcare reform prove that the bishops' desire to promote their own views on reproductive health leads them to play fast and loose with the truth.

5 Oct 2009

FDA approves Bayer's IUD Mirena for treating heavy menstrual bleeding

The U.S. Food and Drug Administration today approved Mirena (levonorgestrel intrauterine system) to treat heavy menstrual bleeding in women who use intrauterine contraception as their method of pregnancy prevention. This is the first intrauterine device approved by the FDA for this additional indication.

3 Oct 2009

HRA Pharma launches its new generation emergency contraceptive in Europe

HRA Pharma (http://www.hra-pharma.com), a privately-held, European pharmaceutical company that designs products, devices and supporting services in reproductive health and endocrinology, announced today that ellaOne(R) (ulipristal acetate, 30mg), its new generation emergency contraceptive, has been launched in France, Germany and the United Kingdom via local HRA teams. HRA Pharma will progressively launch ellaOne in all European countries over the coming months.

1 Oct 2009

Health Canada approves VIBATIV for treating complicated skin and skin structure infections

Astellas Pharma Canada, Inc. announced today that Health Canada has approved VIBATIV(TM) (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.

1 Oct 2009

Stockholders approve BioSante Pharmaceuticals–Cell Genesys merger

BioSante Pharmaceuticals, Inc. and Cell Genesys, Inc., today announced that BioSante stockholders have approved the merger between the two companies with BioSante as the surviving company.

1 Oct 2009

Hologic's ThinPrep integrated imager receives CE marking approval

From Hologic, Inc. 30 Sep 2009

Lecture to focus on the increasing need to fund and develop methods of contraception

On October 2nd, 2009, Henry Gabelnick PhD, Executive Director of The CONRAD Program, will give the prestigious Alan F. Guttmacher lecture at the 2009 Association for Reproductive Health Professionals conference being held in Los Angeles, California.

29 Sep 2009

Maternal Health Task Force and Ashoka to create international fellowship program for young professionals

The Maternal Health Task Force at EngenderHealth and Ashoka will partner to create the first international fellowship program that links committed young professionals with seasoned social entrepreneurs to improve maternal health in developing countries.

28 Sep 2009

The Adiana permanent contraception system supported by UK's NICE

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the United Kingdom's National Institute for Health and Clinical Excellence (NICE), in its updated guidance for hysteroscopic sterilization, supports the use of Hologic's Adiana((R)) permanent contraception system.

25 Sep 2009

NICE updates its guidance on hysteroscopic sterilization

Conceptus, Inc., developer of the Essure procedure, the first proven non-incisional permanent birth control method available, today announced that the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has updated its guidance on hysteroscopic sterilization to support the use of the Essure permanent birth control procedure.

24 Sep 2009

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

Data published today in The Lancet showed a survival benefit in nonsquamous patients with advanced non-small cell lung cancer (NSCLC) who received maintenance therapy with ALIMTA(R) (pemetrexed for injection) plus best supportive care as compared to placebo plus best supportive care.

21 Sep 2009

BioSante and Cell Genesys encourage stockholders to vote shares

BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) and Cell Genesys, Inc. (NASDAQ:CEGE), today jointly announced that RiskMetrics Group – ISS Governance Services, a leading proxy advisory firm, has recommended that BioSante and Cell Genesys stockholders vote “FOR” the adoption of the merger agreement between BioSante and Cell Genesys at their upcoming respective special meeting of stockholders scheduled to be held on September 30, 2009.

18 Sep 2009

Drugs industry names the contraceptive pill as the greatest pharmacy innovation of the past 150 years

The Contraceptive Pill has been crowned the greatest pharmacy innovation of the past 150 years, by leading figures in the drugs industry.

18 Sep 2009

Contraception News and Research

Latest Contraception News and Research

Abortions worldwide decline, unsafe abortions kill 70,000 women annually, report says

Also in Global Health News: Ban addresses women's health; Afghanistan's health services; PMI Africa grants; Q&As

USAID awards Abt Associates 'Strengthening Health Outcomes Through Private Sector' grant

Study reveals that teenage boys are less responsible than girls in preventing chlamydia

Birth control pills may have an impact on choice of partners

Multiple intervention programs can reduce teen pregnancies

Schering-Plough receives FDA recommendation approval for PEGINTRON

Jon O'Brien's statement on healthcare reform

FDA approves Bayer's IUD Mirena for treating heavy menstrual bleeding

HRA Pharma launches its new generation emergency contraceptive in Europe

Health Canada approves VIBATIV for treating complicated skin and skin structure infections

Stockholders approve BioSante Pharmaceuticals–Cell Genesys merger

Hologic's ThinPrep integrated imager receives CE marking approval

Lecture to focus on the increasing need to fund and develop methods of contraception

Maternal Health Task Force and Ashoka to create international fellowship program for young professionals

The Adiana permanent contraception system supported by UK's NICE

NICE updates its guidance on hysteroscopic sterilization

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

BioSante and Cell Genesys encourage stockholders to vote shares

Drugs industry names the contraceptive pill as the greatest pharmacy innovation of the past 150 years

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Contraception News and Research

Latest Contraception News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in